INNV | Ticker Profile - Titan Protect

INNV

InnovAge Holding Corp.

Healthcare · Medical Care Facilities · NMS

$7.30

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.0B

Total market value of the company

Trailing P/E

N/A

Forward P/E

19.55

Based on estimated future earnings — lower means cheaper

Rev Growth

+15.5%

Year-over-year revenue change

Profit Margin

-1.2%

How much profit the company keeps from each dollar of revenue

ROE

-5.9%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$7.00

-4% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 1 analysts covering this stock

About InnovAge Holding Corp.

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.

https://www.innovage.com

Country: United States Employees: 2,440 Industry: Medical Care Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.782

Good returns relative to risk taken

Kelly Fraction

0.0291

Modest edge detected — smaller position warranted

Calmar Ratio

0.623

Acceptable balance between returns and drawdown risk

Annual Return

36.6%

Historical annualised return based on price data

Max Drawdown

-58.7%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.49

Very low correlation to market moves

52W High

$10.69

32% below the year high

52W Low

$3.13

133% above the year low

Avg Volume

295,839

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.9

Days it would take all short sellers to cover — higher means more crowded

Short % Float

4.7%

Low short interest — limited bearish positioning

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-0.08

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

36.25

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.03

Adequate but worth monitoring

Quick Ratio

0.87

Like current ratio but excludes inventory — stricter test

Gross Margin

68.4%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-11.5%

Profit from core operations before interest and tax

Free Cash Flow

$56M

Positive — the business generates more cash than it spends

Revenue (TTM)

$949M

Total revenue over the last 12 months

Net Income

$-11,609,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$7.00

Target Median

$7.00

Target Low

$7.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go